Altium Capital Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-133,333
| Closed | -$4.82K | – | 105 |
|
|
2023
Q1 | $4.82K | Hold |
133,333
| – | – | ﹤0.01% | 83 |
|
|
2022
Q4 | $7.41K | Hold |
133,333
| – | – | ﹤0.01% | 85 |
|
|
2022
Q3 | $5K | Hold |
133,333
| – | – | ﹤0.01% | 123 |
|
|
2022
Q2 | $9K | Hold |
133,333
| – | – | ﹤0.01% | 113 |
|
|
2022
Q1 | $25K | Hold |
133,333
| – | – | 0.01% | 109 |
|
|
2021
Q4 | $77K | Hold |
133,333
| – | – | 0.02% | 121 |
|
|
2021
Q3 | $107K | Hold |
133,333
| – | – | 0.03% | 111 |
|
|
2021
Q2 | $139K | Buy |
+133,333
| New | +$139K | 0.03% | 130 |
|